Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-27

Clinical Trial Update: Acetazolamide Challenge With Perfusion in the Prediction of Cerebral Vasospasm [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating acetazolamide challenge with perfusion to predict cerebral vasospasm following aneurysmal subarachnoid hemorrhage; study completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Subarachnoid Hemorrhage, Aneurysmal, Vasospasm, Cerebral | Phase 4 | Status: COMPLETED | Results posted: 2023-07-27